NDC 0409-3397-52 - NeutroSpec
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0409-3397
- Requested NDC
- 0409-3397-52
- Package NDCs from labels
- 0409-3397-52
- Manufacturer
- Mallinckrodt Inc.
- Effective date
- 2007-10-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| NEUTROSPEC TM Kit for the Preparation of Technetium (99m Tc) fanolesomab | Mallinckrodt Inc. | 2007-10-01 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0409-3397-52 | NeutroSpec | 2 mL in 1 AMPULE | INJECTION, SOLUTION | 2 mL | 500 mg in 1mL | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sodium Bicarbonate | SODIUM BICARBONATE | REMEDYREPACK INC. | 96093b76-5d98-4d2b-b851-20207a8864db | 2026-08-28 | Warnings, Adverse reactions | Sodium Bicarbonate |
| Sodium Bicarbonate | SODIUM BICARBONATE | Exela Pharma Sciences, LLC | f8806ec3-a1c0-47a9-9660-2628dca4623e | 2026-08-25 | Warnings, Adverse reactions | Sodium Bicarbonate |
| Ascorbic Acid | ASCORBIC ACID | Renova Pharmaceuticals LLC | a6481bae-2397-44c7-a51d-4f47ad91bd2c | 2026-08-19 | Warnings, Adverse reactions | Ascorbic Acid |
| sodium bicarbonate | SODIUM BICARBONATE | Baxter Healthcare Corporation | b50c858a-00c8-4cb2-ad73-8797f19e656d | 2026-08-14 | Warnings, Adverse reactions | sodium bicarbonate |
| Sodium Bicarbonate | SODIUM BICARBONATE | Milla Pharmaceuticals Inc. | 2d2035c2-e41b-4d57-a23c-fae16ad9a355 | 2026-08-07 | Warnings, Adverse reactions | Sodium Bicarbonate |
| Sodium Bicarbonate | SODIUM BICARBONATE | Amneal Pharmaceuticals Private Limited | ac91e834-e693-43a2-829b-56793453e8cc | 2026-07-09 | Warnings, Adverse reactions | Sodium Bicarbonate |
| SODIUM BICARBONATE | SODIUM BICARBONATE | HF Acquisition Co LLC, DBA HealthFirst | 9ee46a5b-d00e-4254-e053-2995a90aeb3a | 2026-06-29 | Warnings, Adverse reactions | SODIUM BICARBONATE |
| SODIUM BICARBONATE | SODIUM BICARBONATE | HF Acquisition Co LLC, DBA HealthFirst | d8516f38-6f92-32d1-e053-2995a90a96bf | 2026-06-19 | Warnings, Adverse reactions | SODIUM BICARBONATE |
| Sodium Bicarbonate | SODIUM BICARBONATE, INJECTION | Civica, Inc. | 3737e5e5-2296-4a3d-b8f1-dfea1eff1927 | 2026-06-15 | Warnings, Adverse reactions | Sodium Bicarbonate |
| Sodium Bicarbonate | SODIUM BICARBONATE | Cardinal Health 107, LLC | 60c2a176-8854-4479-b853-d07fe9a1830c | 2026-06-12 | Warnings | Sodium Bicarbonate |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Medical Purchasing Solutions, LLC. | 5401e4ff-aa7a-3e97-e063-6294a90a24f0 | 2026-06-11 | Warnings, Adverse reactions | SODIUM BICARBONATE |
| Sodium Bicarbonate | SODIUM BICARBONATE | Exela Pharma Sciences, LLC | 2f05947f-a489-4298-a871-90db75b2a6c5 | 2026-06-09 | Warnings, Adverse reactions | Sodium Bicarbonate |
| Sodium Bicarbonate | SODIUM BICARBONATE | Vitamex USA, Corp | 5195cab5-bdda-2ddf-e063-6394a90ac9fe | 2026-05-11 | Warnings | Sodium Bicarbonate |
| Sodium Bicarbonate | SODIUM BICARBONATE | TWIN MED LLC | 0f867f56-4bc0-4a85-b9d2-a16282b7c82b | 2026-05-01 | Warnings | Sodium Bicarbonate |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Medical Purchasing Solutions, LLC | 4f97d398-2118-0874-e063-6394a90a4ad1 | 2026-04-16 | Warnings, Adverse reactions | SODIUM BICARBONATE |
| Sodium Bicarbonate | SODIUM BICARBONATE | Hospira, Inc. | ea9f4498-0d43-4043-8dd1-f22537841c21 | 2026-04-06 | Warnings, Adverse reactions | Sodium Bicarbonate |
| Sodium Bicarbonate | SODIUM BICARBONATE | Hospira, Inc. | 8664c7ce-707b-4c6c-9ce4-7160b5f877f8 | 2026-04-06 | Warnings, Adverse reactions | Sodium Bicarbonate |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Hospira, Inc. | 084f5572-8c1f-4802-b179-ca0cc838fc68 | 2026-03-09 | Warnings, Adverse reactions | SODIUM BICARBONATE |
| Sodium Bicarbonate | SODIUM BICARBONATE | Hospira, Inc. | 0c24b592-4bc8-456f-acac-9c9525844a06 | 2026-03-09 | Warnings, Adverse reactions | Sodium Bicarbonate |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Amneal Pharmaceuticals Private Limited | ba92f45a-0187-4709-aa70-462b8dae09e9 | 2026-02-09 | Warnings, Adverse reactions | SODIUM BICARBONATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.